版本:
中国

BRIEF-PDL BioPharma announces settlement of Keytruda lawsuit with Merck

April 24 PDL BioPharma Inc:

* PDL BioPharma announces settlement of Keytruda patent infringement lawsuit with Merck

* PDL BioPharma Inc - under terms of agreement, Merck will pay company a one time, lump-sum payment of $19.5 million

* PDL BioPharma Inc - company will grant Merck a fully paid-up, royalty free, non-exclusive license to certain of company's Queen et al

* PDL BioPharma Inc - in addition, parties agreed to dismiss all claims in relevant legal proceedings

* PDL BioPharma Inc - as a result of settlement, expect to recognize $19.5 million in license revenue for q2 ending june 30, 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐